Home > Drug Search >
  • Targets: Calpain
  •   > 
Drug Filter
Category:
chemistry (25) biology (8)
Status:
Approved (1) Phase Ⅲ (3) Phase Ⅱ (11) Phase Ⅰ (18)
Clinical Stage:
Pending (4) Active (19) Discontinued (9)
Bio-Type:
Gene therapy (1) Vaccine (1) Whole antibody (4)
Company:
Edison pharmaceuticals (1) Endo (1) Genentech (1) Hospira (1) Ionis Pharmaceuticals (1) Janssen (1) Japan Tobacco (1) Lilly (1) Medivation (1) Nippon Shinyaku Pharma (1) Paion Pharma (1) Paladin Pharma (1) Pfizer (1) Roche (1) Simcere (1) TauRx Pharmaceuticals (2) Tohoku University (1) Samung Medical centre (1) Asan Medical Center (1) iPierian (1) C2N Diagnostics (1) Brigham and Women's Hospital (1) NitroMed (1) Axon Biochemicals (1) Aerpio Therapeutics (1) reMYND (1) Siemens Medical Solution (1) Raptor Pharmaceutical (1) vTv Therapeutics (1) Akebia Therapeutics (1) Nivalis Therapeutics (1) QR Pharma (1) Tasly Pharm (1) Harvard University (1) Rebiotix (1) National Research Development (1) Catabasis (1) DiaMedica (1) Yene Pharma (1) sGC Pharma (1) Kaneq Bioscience (1) ProteoTech (1) Ionis Pharmaceuticals (1) AC Immune (2) GE Healthcare (1) Abbott (1) Abbvie (2) Bristol-Myers Squibb (1)
Indication:
Non-alcoholic steatohepatitis (1) Alzheimer's disease (AD) (19) Asthma (1) Chronic obstructive pulmonary disease (COPD) (1) Cognitive disorders (1) Cystic fibrosis (CF) (1) Dementia (2) Diabetic macular edema (1) Hypercholesterolemia (1) Hypertension (1) Leukemia (1) Parkinson's disease (PD) (1) Solid tumours (1) Type 2 diabetes (4) Stroke (1) Retinal vein occlusion (1) Progressive supranuclear palsy (3) Clostridial infection (1) Insulin resistance (1) Mild cognitive impairment(MCI) (1) Inherited mitochondrial respiratory chain diseases (1)
Aprv. Year:
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top